Search Results - "Morishita, Ryuichi"

PubPharm (934)

1

Efficacy and safety in mice of repeated, lifelong administration of an ANGPTL3 vaccine

in: NPJ vaccines | 2023

by Fukami, H. | Morinaga, J. | Nakagami, H. | +12

2

IMPROVED DNA VACCINE FOR SARS-COV-2

in: Europäisches Patentamt | 2023

by NAKAGAMI HIRONORI | MORISHITA RYUICHI | HAYASHI HIROKI | +6

3

IMMUNOGENIC COMPOSITION TARGETING PHOSPHORYLATED TAU PROTEIN

in: Europäisches Patentamt | 2023

by NAKAGAMI HIRONORI | MORISHITA RYUICHI | TAKEDA SHUKO | +1

4

Long Term Follow-Up Study of a Randomized, Open-Label, Uncontrolled, Phase I/II Study to Assess the Safety and Immunogenicity of Intramuscular and Intradermal Doses of COVID-19 DNA Vaccine (AG0302-COVID19)

in: Vaccines | 2023

by Nakagami, H. | Matsumoto, T. | Takazawa, K. | +5

5

Acquisition of Humoral Immune Responses in Convalescent Japanese People with SARS-CoV-2 (COVID-19) Infection in 2021

in: Preprints.org | 2023

by Monzen, K. | Watanabe, T. | Okabe, T. | +3

6

Acquisition of Humoral Immune Responses in Convalescent Japanese People with SARS-CoV-2 (COVID-19) Infection in 2021

in: Viruses | 2023

by Monzen, K. | Watanabe, T. | Okabe, T. | +3

7

Intradermal administration of DNA vaccine targeting Omicron SARS-CoV-2 via pyro-drive jet injector provides the prolonged neutralizing antibody production via germinal center reaction

in: Scientific reports | 2023

by Hayashi, H. | Sun, J. | Yanagida, Y. | +16

8

WNT SIGNALING PATHWAY INHIBITOR

in: Europäisches Patentamt | 2023

by SHIMAMURA MUNEHISA | NAKAGAMI HIRONORI | MORISHITA RYUICHI

9

CONJUGATE VACCINE TARGETING DISORDER-CAUSING IN VIVO PROTEIN

in: Europäisches Patentamt | 2023

by NAKAGAMI YOSHINORI | MORISHITA RYUICHI | TENMAN AKIKO

10

IMMUNOGENIC COMPOSITION TARGETING PHOSPHORYLATED TAU PROTEIN

in: Europäisches Patentamt | 2023

by NAKAGAMI HIRONORI | MORISHITA RYUICHI | TAKEDA SHUKO | +1

1
2
3
4
5
6
7
8
9
10
11
Next »
[94]